Market Capitalization of Glenmark Pharmaceuticals (GLENMARK)
As of July 24, 2026, Glenmark Pharmaceuticals (GLENMARK) market capitalisation is ₹63198.87 Cr ($7.02B), with 28.83 Cr shares outstanding at a current price of ₹2192.00 on NSE, ranking 173 out of 5363 companies by market cap in our screener. Glenmark Pharmaceuticals operates in the Healthcare sector and is classified as a Large Cap stock. View GLENMARK 52-week chart for the annual high/low range and current price position.
Market Cap History of Glenmark Pharmaceuticals (Last 10 Years)
GLENMARK market capitalisation from year-end NSE closing prices over the last 10 years. For live price, earnings and the complete company profile, see GLENMARK share price screener.
End of Year Market Cap History — Glenmark Pharmaceuticals
GLENMARK year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. Compare with Glenmark Pharmaceuticals value estimation to assess whether the stock is under or overvalued.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹63198.87 Cr
$7.02B USD
|
₹2192.00 | NSE | +7.70% |
| 2025 |
₹58678.07 Cr
$6.52B USD
|
₹2035.20 | NSE | +26.48% |
| 2024 |
₹46392.93 Cr
$5.15B USD
|
₹1609.10 | NSE | +88.43% |
| 2023 |
₹24620.75 Cr
$2.74B USD
|
₹853.95 | NSE | +101.33% |
| 2022 |
₹12228.92 Cr
$1.36B USD
|
₹424.15 | NSE | -19.75% |
| 2021 |
₹15238.94 Cr
$1.69B USD
|
₹528.55 | NSE | +7.10% |
| 2020 |
₹14228.40 Cr
$1.58B USD
|
₹493.50 | NSE | +42.03% |
| 2019 |
₹10017.54 Cr
$1.11B USD
|
₹347.45 | NSE | -49.87% |
| 2018 |
₹19981.74 Cr
$2.22B USD
|
₹693.05 | NSE | +16.53% |
| 2017 |
₹17147.59 Cr
$1.91B USD
|
₹594.75 | NSE | -33.06% |
| 2016 |
₹25615.44 Cr
$2.85B USD
|
₹888.45 | NSE | -3.63% |
| 2015 |
₹26579.85 Cr
$2.95B USD
|
₹921.90 | NSE | +19.70% |
| 2014 |
₹22206.10 Cr
$2.47B USD
|
₹770.20 | NSE | +44.27% |
| 2013 |
₹15391.75 Cr
$1.71B USD
|
₹533.85 | NSE | +1.00% |
| 2012 |
₹15238.94 Cr
$1.69B USD
|
₹528.55 | NSE | +80.05% |
| 2011 |
₹8463.52 Cr
$940.39M USD
|
₹293.55 | NSE | -18.93% |
| 2010 |
₹10439.92 Cr
$1.16B USD
|
₹362.10 | NSE | +31.27% |
| 2009 |
₹7953.20 Cr
$883.69M USD
|
₹275.85 | NSE | -6.84% |
| 2008 |
₹8537.04 Cr
$948.56M USD
|
₹296.10 | NSE | -50.32% |
| 2007 |
₹17183.63 Cr
$1.91B USD
|
₹596.00 | NSE | +97.78% |
| 2006 |
₹8688.40 Cr
$965.38M USD
|
₹301.35 | NSE | +92.21% |
| 2005 |
₹4520.22 Cr
$502.25M USD
|
₹156.78 | NSE | +29.34% |
| 2004 |
₹3494.97 Cr
$388.33M USD
|
₹121.22 | NSE | +238.89% |
| 2003 |
₹1031.31 Cr
$114.59M USD
|
₹35.77 | NSE | - |